On-premise Cervical AI Cytology Solution
Landing Med's on-premise AI cervical cytology algorithm provides secure, offline, AI-powered analysis for cervical cytology diagnosis. Utilizing scanned WSIs from the LD Patho 320A or LD Cyto 2200 scanners, our robust AI algorithm, trained on over 10 million samples, autonomously processes and identifies areas of interest, streamlining physicians' workflow and enhancing accuracy in cervical AI cytology interpretation.
By operating entirely offline, our LD CytoBrain system ensures that all data remains securely on-site, eliminating cloud dependency and safeguarding patient privacy. This robust solution integrates seamlessly into laboratory environments, empowering healthcare providers with efficient, reliable, and secure diagnostic support for AI cervical cancer screening.
End-to-end Cervical AI Cytology System
Landing Med is a comprehensive provider of AI cervical cancer screening solutions, offering an end-to-end AICCS platform that streamlines and enhances the entire screening process. From liquid-based cytology kits to slide preparation equipment, digital pathology slide scanners, and robust AI-assisted analysis, Landing Med empowers laboratories and healthcare providers with integrated, affordable and efficient screening tools. Our innovative Cyto AISCAN simplifies digital cytopathology workflows and improves diagnostic performance, ensuring high-quality care in AI cervical cancer screening solutions.
Liquid Based Cytology (LBC) Consumables
Slide Preparation Equipment
WSI Digital Slide Scanner
AI Analysis & Reporting
Landing Med aims to make early cancer detection technologies accessible to all. We provide affordable AI cytology and digital histopathology scanner options as well as services for pathologists, cytologists and governments. By integrating automation, digital, AI, and cloud computing technologies into Pap smear testing, our lab successfully screened 1 million cervical cytology cases in 50 days.
Sign in to leave a comment.